David A. Scheinberg
David Scheinberg Elected to the Association of American Physicians

David A. Scheinberg has been elected a member of the prestigious Association of American Physicians (AAP).

Friday, May 1, 2009
Charles L. Sawyers
Charles Sawyers Awarded Landon Prize

Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, has been awarded the 2009 Dorothy P. Landon Prize for Translational Cancer Research from the American Association for Cancer Research.

Friday, May 1, 2009
Pictured: Joan Massagué
Cancer Biologist Joan Massagué Honored on Two Continents

Joan Massagué, Chair of the Cancer Biology and Genetics Program in the Sloan Kettering Institute, has been named the recipient of two prestigious awards.

Friday, May 1, 2009
Drug Shows Activity in Men with Advanced Prostate Cancer

A new multi-center study shows that an experimental drug lowers prostate specific antigen (PSA) levels - a marker for tumor growth - in men with advanced prostate cancer for whom traditional treatment options have failed.

Thursday, April 9, 2009
Michel Sadelain
Investigators Harness microRNAs for Therapeutic Cell Engineering

Memorial Sloan Kettering Cancer Center investigators have found a new technique to control gene expression in mice.

Sunday, March 1, 2009
Major Trends in Modern Cancer Research

The third annual research symposium introduces high school students and teachers to several topics in cancer research.

Sunday, March 1, 2009
A Day in the Life: A Glimpse into the World of Two Gerstner Sloan Kettering Graduate School Students

A glimpse into the world of two Gerstner Sloan Kettering Graduate School students.

Sunday, March 1, 2009
The Art and Politics of Science by Harold Varmus Is Published

In February, Harold Varmus’ memoir about his life in science was published.

Sunday, March 1, 2009
Research Shows Cell's Inactive State is Critical for Effectiveness of Cancer Treatment

A new study sheds light on a little understood biological process called quiescence, which enables blood-forming stem cells to exist in a dormant or inactive state in which they are not growing or dividing. According to the study’s findings, researchers identified the genetic pathway used to maintain a cell’s quiescence, a state that allows bone marrow cells to escape the lethal effects of standard cancer treatments.

Friday, January 9, 2009
Starr Cancer Consortium Retreat Promotes Collaboration Among Grant Awardees

Memorial Sloan Kettering researchers gathered with scientists from four other institutions at Cold Spring Harbor Laboratory on Long Island in September to present and discuss projects funded by the Starr Cancer Consortium.

Monday, December 1, 2008